Aimovig vs. Topamax

See how Aimovig and Topamax compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Aimovig is a once-monthly injectable CGRP blocker for migraine prevention, while Topamax is a daily oral anticonvulsant tablet also approved to prevent migraine.

  • Aimovig's most common side effects center on the injection site, while Topamax commonly causes tingling, fatigue, and appetite loss, especially during dose titration.

  • Topamax is available as an inexpensive generic tablet, while Aimovig has no generic option and typically costs several times more per month.

Aimovig vs. Topamax Drug Summary

Aimovig

Aimovig is a CGRP receptor antagonist monoclonal antibody used for the preventive treatment of migraine in adults. It's given as a once-monthly subcutaneous injection using a prefilled autoinjector or syringe. Aimovig does not treat migraine attacks that have already started.

Topamax

Topamax is an anticonvulsant (topiramate) approved for migraine prevention in adults and adolescents 12 and older, and for certain seizure disorders. It's a daily tablet, started low and increased over several weeks to a maintenance dose. It hasn't been studied for treating an active migraine attack.

Aimovig vs. Topamax Side Effects

Aimovig

Most common
Injection site reactions (5-6%)
Constipation (up to 3%)
Cramps/muscle spasms (up to 2%)

Topamax

Most common
Paresthesia (up to 51%)
Fatigue (up to 15%)
Anorexia (up to 15%)

Aimovig vs. Topamax Dosage

Aimovig

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 70 mg once monthly At the start
Maximum dose 140 mg once monthly If needed
Dose changes 1 increase As tolerated

Topamax

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 25 mg/day Week 1
Maximum dose Up to 200 mg/day If needed
Dose changes 5 increases Every week

Aimovig vs. Topamax Indications

Aimovig

Aimovig is FDA-approved only for preventing migraine before it starts, not for treating an attack in progress. It works by blocking the CGRP receptor involved in transmitting migraine pain signals.

  • Preventive treatment of episodic migraine

  • Preventive treatment of chronic migraine

  • Approved for adults only, not teens

  • Self-administered once-monthly injection

Topamax

Topamax is FDA-approved to prevent migraine in adults and adolescents 12 and older, and separately to treat several types of epilepsy. Like Aimovig, it hasn't been studied for stopping a migraine attack once it has started.

  • Preventive treatment of migraine, ages 12+

  • Initial monotherapy for certain seizures

  • Adjunctive therapy for partial-onset seizures

  • Approved for Lennox-Gastaut syndrome seizures

Aimovig vs. Topamax Pros and Cons

Aimovig

Aimovig's monthly dosing and CGRP-targeted mechanism mean most patients avoid the cognitive fog and weight changes linked to older oral preventives. It has no generic version yet, so cost and insurance approval are common hurdles.

Pros

  • Only one injection needed per month

  • Few systemic side effects reported in trials

  • No cognitive fog like some oral preventives

  • No liver-enzyme drug interactions

Cons

  • Roughly $783 to $943 per month before insurance

  • Requires self-injection, not a pill

  • No generic version currently available

  • Insurance often requires prior authorization

Topamax

Topamax is a well-established oral option with decades of clinical use and low-cost generics. Its trade-off is a slower titration and a higher rate of side effects like tingling and cognitive slowing during dose increases.

Pros

  • Low-cost generic tablet, widely available

  • Also treats several types of epilepsy

  • Decades of clinical use since approval

  • Roughly $20 to $130 per month before insurance

Cons

  • Tingling affects over half of patients

  • Multi-week titration schedule required

  • Can cause word-finding, concentration issues

  • Not safe during pregnancy, birth defect risk

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.